RA Capital Management - DICERNA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
RA Capital Management ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$35,278,000
-8.8%
2,456,6690.0%2.10%
+1.2%
Q2 2019$38,693,000
+7.5%
2,456,6690.0%2.08%
+33.8%
Q1 2019$35,990,000
+37.0%
2,456,6690.0%1.55%
+1.5%
Q4 2018$26,262,000
-56.2%
2,456,669
-37.5%
1.53%
-52.4%
Q3 2018$60,025,000
+24.6%
3,933,4890.0%3.21%
+2.6%
Q2 2018$48,185,000
+28.1%
3,933,4890.0%3.13%
+8.6%
Q1 2018$37,604,000
-16.1%
3,933,489
-20.8%
2.88%
-23.2%
Q4 2017$44,839,000
+221.1%
4,965,513
+104.5%
3.75%
+197.3%
Q3 2017$13,964,000
+81.4%
2,428,5710.0%1.26%
+42.9%
Q2 2017$7,699,000
-6.8%
2,428,5710.0%0.88%
-12.8%
Q1 2017$8,257,000
+18.1%
2,428,5710.0%1.01%
+2.2%
Q4 2016$6,994,000
-51.0%
2,428,5710.0%0.99%
-32.7%
Q3 2016$14,280,000
+96.0%
2,428,5710.0%1.47%
+46.0%
Q2 2016$7,286,000
-44.0%
2,428,5710.0%1.01%
-39.4%
Q1 2016$13,017,000
-54.8%
2,428,5710.0%1.66%
-41.7%
Q4 2015$28,827,000
+44.6%
2,428,5710.0%2.85%
-0.4%
Q3 2015$19,939,000
-41.1%
2,428,5710.0%2.86%
-16.0%
Q2 2015$33,879,000
-41.9%
2,428,5710.0%3.41%
-41.2%
Q1 2015$58,359,000
+45.9%
2,428,5710.0%5.80%
+34.8%
Q4 2014$39,999,000
+29.4%
2,428,5710.0%4.30%
+17.7%
Q3 2014$30,916,000
-43.6%
2,428,5710.0%3.65%
-34.1%
Q2 2014$54,813,000
-20.1%
2,428,5710.0%5.54%
+12.6%
Q1 2014$68,607,0002,428,5714.92%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 2,062,991$7,014,0001.85%
RA Capital Management 2,428,571$8,257,0001.01%
Omega Fund Management, LLC 223,457$760,0000.49%
683 Capital Management, LLC 800,000$2,720,0000.42%
EcoR1 Capital, LLC 382,000$1,299,0000.33%
Eventide Asset Management 377,000$1,282,0000.08%
Palo Alto Investors LP 481,519$1,637,0000.08%
SABBY MANAGEMENT, LLC 200,000$680,0000.04%
BOURGEON CAPITAL MANAGEMENT LLC 13,500$46,0000.03%
Quotient Investors, LLC 13,600$46,0000.03%
View complete list of DICERNA PHARMACEUTICALS INC shareholders